These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9500679)

  • 1. Analysis of gene expression patterns in small amounts of human ventricular myocardium by a multiplex RNase protection assay.
    Mittmann C; Münstermann U; Weil J; Böhm M; Herzig S; Nienaber C; Eschenhagen T
    J Mol Med (Berl); 1998 Feb; 76(2):133-40. PubMed ID: 9500679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts.
    Schwinger RH; Böhm M; Schmidt U; Karczewski P; Bavendiek U; Flesch M; Krause EG; Erdmann E
    Circulation; 1995 Dec; 92(11):3220-8. PubMed ID: 7586307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.
    Flesch M; Schwinger RH; Schnabel P; Schiffer F; van Gelder I; Bavendiek U; Südkamp M; Kuhn-Regnier F; Böhm M
    J Mol Med (Berl); 1996 Jun; 74(6):321-32. PubMed ID: 8862513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium.
    Arai M; Alpert NR; MacLennan DH; Barton P; Periasamy M
    Circ Res; 1993 Feb; 72(2):463-9. PubMed ID: 8418995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.
    Lowes BD; Minobe W; Abraham WT; Rizeq MN; Bohlmeyer TJ; Quaife RA; Roden RL; Dutcher DL; Robertson AD; Voelkel NF; Badesch DB; Groves BM; Gilbert EM; Bristow MR
    J Clin Invest; 1997 Nov; 100(9):2315-24. PubMed ID: 9410910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart.
    Prestle J; Dieterich S; Preuss M; Bieligk U; Hasenfuss G
    Cardiovasc Res; 1999 Aug; 43(2):323-31. PubMed ID: 10536662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction.
    Feldman AM; Ray PE; Silan CM; Mercer JA; Minobe W; Bristow MR
    Circulation; 1991 Jun; 83(6):1866-72. PubMed ID: 2040039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene.
    Takahashi T; Allen PD; Izumo S
    Circ Res; 1992 Jul; 71(1):9-17. PubMed ID: 1535030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unchanged protein expression of sarcoplasmic reticulum Ca2+-ATPase, phospholamban, and calsequestrin in terminally failing human myocardium.
    Münch G; Bölck B; Hoischen S; Brixius K; Bloch W; Reuter H; Schwinger RH
    J Mol Med (Berl); 1998 May; 76(6):434-41. PubMed ID: 9625300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts.
    Linck B; Bokník P; Eschenhagen T; Müller FU; Neumann J; Nose M; Jones LR; Schmitz W; Scholz H
    Cardiovasc Res; 1996 Apr; 31(4):625-32. PubMed ID: 8689655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure.
    Eschenhagen T; Mende U; Nose M; Schmitz W; Scholz H; Haverich A; Hirt S; Döring V; Kalmár P; Höppner W
    Circ Res; 1992 Apr; 70(4):688-96. PubMed ID: 1551195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles.
    Reiser PJ; Portman MA; Ning XH; Schomisch Moravec C
    Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1814-20. PubMed ID: 11247796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Changes in Children with Heart Failure Undergoing Left Ventricular Assist Device Therapy.
    Medina E; Sucharov CC; Nelson P; Miyamoto SD; Stauffer BL
    J Pediatr; 2017 Mar; 182():184-189.e1. PubMed ID: 27908653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium.
    Movsesian MA; Karimi M; Green K; Jones LR
    Circulation; 1994 Aug; 90(2):653-7. PubMed ID: 8044934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of mRNA specific for beta 1- and beta 2-adrenergic receptors in human failing hearts. Evaluation of the absolute cardiac mRNA levels by two independent methods.
    Ihl-Vahl R; Eschenhagen T; Kübler W; Marquetant R; Nose M; Schmitz W; Scholz H; Strasser RH
    J Mol Cell Cardiol; 1996 Jan; 28(1):1-10. PubMed ID: 8745209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.
    Tsutsumi Y; Matsubara H; Ohkubo N; Mori Y; Nozawa Y; Murasawa S; Kijima K; Maruyama K; Masaki H; Moriguchi Y; Shibasaki Y; Kamihata H; Inada M; Iwasaka T
    Circ Res; 1998 Nov; 83(10):1035-46. PubMed ID: 9815151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
    Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
    J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
    Stein B; Eschenhagen T; Rüdiger J; Scholz H; Förstermann U; Gath I
    J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure.
    Studer R; Reinecke H; Bilger J; Eschenhagen T; Böhm M; Hasenfuss G; Just H; Holtz J; Drexler H
    Circ Res; 1994 Sep; 75(3):443-53. PubMed ID: 8062418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved Frank-Starling mechanism in human end stage heart failure.
    Weil J; Eschenhagen T; Hirt S; Magnussen O; Mittmann C; Remmers U; Scholz H
    Cardiovasc Res; 1998 Feb; 37(2):541-8. PubMed ID: 9614508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.